Subscribe To
Snbl to acquire satsuma pharmaceuticals
Transaction delivers immediate value and liquidity to satsuma stockholders SNBL to acquire all outstand...
April 16, 2023, 11:41 pm
satsuma pharmaceuticals provides sts101 development program and corporate update
Further analysis of results from recently-completed SUMMIT Phase 3 efficacy trial of STS101 for the acute treatment of migraine shows differentiating ...
December 20, 2022, 2:21 pm